Article Text

Download PDFPDF
Risk Factors and Indications for 30-Day Readmission After Primary Surgery for Epithelial Ovarian Cancer
  1. Mariam AlHilli, MBBCh*,
  2. Carrie Langstraat, MD*,
  3. Christine Tran, BS, BA,
  4. Janice Martin, RN,
  5. Amy Weaver, MS§,
  6. Michaela McGree, BS§,
  7. Andrea Mariani, MD*,
  8. William Cliby, MD* and
  9. Jamie Bakkum-Gamez, MD*
  1. *Division of Gynecologic Surgery, Department of Obstetrics and Gynecology;
  2. Mayo Medical School;
  3. Surgery Research; and
  4. §Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
  1. Address correspondence and reprint requests to Jamie Bakkum-Gamez, MD, Eisenberg Lobby 71, Mayo Clinic, 200 First St, SW, Rochester, MN 55905. E-mail: bakkum.jamie{at}mayo.edu.

Abstract

Background To identify patients at risk for postoperative morbidities, we evaluated indications and factors associated with 30-day readmission after epithelial ovarian cancer surgery.

Methods Patients undergoing primary surgery for epithelial ovarian cancer between January 2, 2003, and December 29, 2008, were evaluated. Univariable and multivariable logistic regression models were fit to identify factors associated with 30-day readmission. A parsimonious multivariable model was identified using backward and stepwise variable selection.

Results In total, 324 (60.2%) patients were stage III and 91 (16.9%) were stage IV. Of all 538 eligible patients, 104 (19.3%) were readmitted within 30 days. Cytoreduction to no residual disease was achieved in 300 (55.8%) patients, and 167 (31.0%) had measurable disease (≤1 cm residual disease). The most common indications for readmission were surgical site infection (SSI; 21.2%), pleural effusion/ascites management (14.4%), and thromboembolic events (12.5%). Multivariate analysis identified American Society of Anesthesiologists score of 3 or higher (odds ratio, 1.85; 95% confidence interval, 1.18–2.89; P = 0.007), ascites [1.76 (1.11–2.81); P = 0.02], and postoperative complications during initial admission [grade 3–5 vs none, 2.47 (1.19–5.16); grade 1 vs none, 2.19 (0.98–4.85); grade 2 vs none, 1.28 (0.74–2.21); P = 0.048] to be independently associated with 30-day readmission (c-index = 0.625). Chronic obstructive pulmonary disease was the sole predictor of readmission for SSI (odds ratio, 3.92; 95% confidence interval, 1.07–4.33; P = 0.04).

Conclusions Clinically significant risk factors for 30-day readmission include American Society of Anesthesiologists score of 3 or higher, ascites and postoperative complications at initial admission. The SSI and pleural effusions/ascites are common indications for readmission. Systems can be developed to predict patients needing outpatient management, improve care, and reduce costs.

  • Readmission
  • Ovarian cancer
  • Primary cytoreduction

Statistics from Altmetric.com

Footnotes

  • Supported by the Office of Women’s Health Research Building Interdisciplinary Careers in Women’s Health (BIRCWH award K12 HD065987).

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.